This module will address unique issues that affect dietary supplements and discuss where the United States Food and Drug Administration (FDA) does and does not control certain aspects of quality. This module will also explore the confusion between absorption, bioavailability and bioefficacy.
After completing this enduring material, participants should be able to:
- Discuss important quality issues that are not addressed by the FDA’s Current Good Manufacturing Practice (CGMP) regulations.
- Asses the challenges related to botanical species, plant parts and extraction methods.
- Examine the differences between wildcrafting and cultivation of medicinal herbs.
- Discuss how bioavailability influences efficacy and why many botanicals with low bioavailability can be efficacious.
Released On: September 28, 2021
Expires On: September 27, 2024
Credit Available: Maximum of 1 AMA PRA Category 1 Credit(s)™